New brain scan method aims to spot Alzheimer's and Parkinson's early

NCT ID NCT06080659

Recruiting now Knowledge-focused Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a new, low-cost type of brain scan can find early signs of Alzheimer's and Parkinson's disease. Researchers will compare brain scans from 120 people, including those at risk for Alzheimer's, those with Parkinson's, and healthy volunteers. The goal is to see if these scans can serve as a simple, non-invasive biomarker for early diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, EARLY ONSET are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease early-onset autosomal dominant Alzheimer disease Parkinson disease subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE, EARLY ONSET PARKINSON DISEASE

Contacts and locations

Locations

CHU Rennes
RECRUITING

Rennes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.